Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
P45 - Novel Therapeutics and Targeted Therapies - ALK/ROS1/MET
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P45.08 - Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China
00:00 - 00:00 | Presenter: Shun Lu
- Abstract
Loading...
-
+
P61 - Screening and Early Detection - Engagement in Lung Cancer Screening
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Screening and Early Detection
-
+
P61.01 - Intelligence Assistant Million Early-Stage Lung Cancer Research Program in China
00:00 - 00:00 | Presenter: Dawei Yang
- Abstract
Loading...
-
+
WS06 - Joint IASLC - CAALC - CSCO Workshop: Looking Toward the Future: Recognizing and Curing Lung Cancer
- 22:15 - 23:45
- 9/11/2021
- Location: Program Auditorium
- Not for CME Credit
- Type: Workshop
- Track: N.A.
- Moderators:Caicun Zhou, ChunXue Bai
-
+
WS06.01 - Introduction
22:15 - 22:17 | Presenter: ChunXue Bai, Caicun Zhou
- Abstract
No abstract available for this presentation
-
+
WS06.02 - RWS on PNapp MIOT Study on Pulmonary Nodule and Updates of 9th Edition of NSCLC TNM Staging Project in China
22:17 - 22:29 | Presenter: Dawei Yang
- Abstract
No abstract available for this presentation
-
+
WS06.03 - Neoadjuvant/Adjuvant Target Therapy for Curing Driver Genes Positive Resectable NSCLC
22:29 - 22:41 | Presenter: Wen-zhao Zhong
- Abstract
No abstract available for this presentation
-
+
WS06.04 - Neoadjuvant/Adjuvant Immunotherapy for Curing Non-driver Genes Resectable NSCLC
22:41 - 22:53 | Presenter: Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
WS06.05 - RATIONALE-307: Updated Biomarker Analysis of Phase 3 Study of Tislelizumab Plus Chemo vs Chemo Alone For 1L Advanced Sq-NSCLC
22:53 - 23:03 | Presenter: Jie Wang
- Abstract
Loading... -
+
WS06.06 - Drug Holiday Based on Minimal Residual Disease Status After Local Therapy Following EGFR-TKI Treatment for Patients With Advanced NSCLC
23:03 - 23:13 | Presenter: Song Dong
- Abstract
Loading... -
+
WS06.07 - Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety Data from a Phase 2 Study in China
23:13 - 23:23 | Presenter: Shun Lu
- Abstract
Loading... -
+
WS06.08 - Discussant
23:23 - 23:31 | Presenter: Mingfang Zhao
- Abstract
No abstract available for this presentation
-
+
WS06.09 - Live Panel Discussion with Speakers and Chairs
23:31 - 23:45 | Presenter: Yi-Long Wu, Tony Mok
- Abstract
No abstract available for this presentation
